Patents by Inventor Simcha Yagel

Simcha Yagel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9797911
    Abstract: An isolated polypeptide comprising an amino acid sequence at least 70% homologous to SEQ ID NO: 4 and an isolated polynucleotide encoding same are disclosed. A polynucleotide comprising a nucleic acid sequence capable of specifically hybridizing to the isolated polynucleotide and an isolated antibody comprising an antigen recognition domain which specifically binds the isolated polypeptide are also disclosed. Pharmaceutical compositions, methods of diagnosing and treating comprising same are also disclosed.
    Type: Grant
    Filed: June 15, 2014
    Date of Patent: October 24, 2017
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Eli Keshet, Shay Sela, Ahuva Itin, Simcha Yagel
  • Publication number: 20140295454
    Abstract: An isolated polypeptide comprising an amino acid sequence at least 70% homologous to SEQ ID NO: 4 and an isolated polynucleotide encoding same are disclosed. A polynucleotide comprising a nucleic acid sequence capable of specifically hybridizing to the isolated polynucleotide and an isolated antibody comprising an antigen recognition domain which specifically binds the isolated polypeptide are also disclosed. Pharmaceutical compositions, methods of diagnosing and treating comprising same are also disclosed.
    Type: Application
    Filed: June 15, 2014
    Publication date: October 2, 2014
    Inventors: Eli KESHET, Shay Sela, Ahuva Itin, Simcha Yagel
  • Publication number: 20100136012
    Abstract: An isolated polypeptide variant of VEGFR comprising an amino acid sequence at least 70% homologous to SEQ ID NO: 4 and an isolated polynucleotide encoding same are disclosed. A polynucleotide comprising a nucleic acid sequence capable of specifically hybridizing to the isolated polynucleotide and an isolated antibody comprising an antigen recognition domain which specifically binds the isolated polypeptide are also disclosed. Pharmaceutical compositions, methods of diagnosing and treating comprising same are also disclosed.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 3, 2010
    Applicants: Hadasit Medical Research Services and Development Ltd.
    Inventors: Eli Keshet, Shay Sela, Ahuva Ithin, Simcha Yagel